Americans have unrealistic expectations for a COVID-19 vaccine

Two in five Americans say they don't want a COVID-19 vaccine, which is a problem. Finding out what Americans do want from a vaccine might help.

Matt Motta, Assistant Professor of Political Science, Oklahoma State University • conversation
Jan. 13, 2021 ~9 min

covid-19 coronavirus vaccines herd-immunity covid-19-vaccine vaccine-safety vaccine-hesitancy moderna-vaccine pfizer-vaccine

Vaccine delays reveal unexpected weak link in supply chains: A shortage of workers

The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.

Anna Nagurney, John F. Smith Memorial Professor of Operations Management, University of Massachusetts Amherst • conversation
Jan. 8, 2021 ~10 min

covid-19 coronavirus covid-19-vaccines moderna-vaccine pfizer-vaccine vaccine-distribution

Why it matters that the coronavirus is changing – and what this means for vaccine effectiveness

A new strain of the SARS-CoV-2 virus that causes COVID-19 appears to be spreading fast in the the UK. What does this mean for vaccine developers and vaccinations?

David Kennedy, Assistant Professor of Biology, Penn State • conversation
Dec. 22, 2020 ~6 min

 health  medicine  covid-19  coronavirus  pandemic  sars-cov-2  ace2  pfizer  pfizerbiontech-vaccine  moderna-vaccine

The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 – and then developing multiple vaccines

The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.

David Pride, Associate Director of Microbiology, University of California San Diego • conversation
Dec. 17, 2020 ~11 min

 innovation  genome  covid-19  immune-system  pandemic  vaccines  sars-cov-2  remdesivir  drug-development  monoclonal-antibodies  astrazeneca  pfizerbiontech-vaccine  moderna-vaccine  pfizer-vaccine

Oxford-AstraZeneca vaccine is cheaper than Pfizer's and Moderna's and doesn't require supercold temperature

There is now a third vaccine that prevents COVID-19 infections. It isn't quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.

Sanjay Mishra, Project Coordinator & Staff Scientist, Vanderbilt University Medical Center, Vanderbilt University • conversation
Nov. 24, 2020 ~9 min

 covid-19  immune-system  pandemic  vaccines  sars-cov-2  antibody  university-of-oxford  astrazeneca  covid-19-vaccines  pfizerbiontech-vaccine  moderna-vaccine  pfizer-vaccine

/

1